Use of (R)-penciclovir triphosphate for the manufacture of a medicament for the treatment of viral diseases
OwnerRichard Vere Hodge, Raymond Schinaziinventors
Life of this patent
Estimating the term…
Abstract
A method of treatment of: i) HIV-1 infections in mammals, including humans; or ii) HBV infections in mammals, including humans; which method comprises the administration to the human in need of such treatment, an effective amount of the (R)-enantiomer of the triphosphate of a compound of formula (A) or a pharmaceutically acceptable salt thereof; and compounds for use in the method.
Claims7
A method of treatment of:
- i) HIV-1 infections in mammals, including humans;
- or
- ii) HBV infections in mammals, including humans;
- which method comprises the administration to the human in need of such treatment, an effective amount of the (R)-enantiomer of the triphosphate of a compound of formula (A):
- or a pharmaceutically acceptable salt thereof.
Use of the (R)-enantiomer of the triphosphate of a compound of formula (A):
- or a pharmaceutically acceptable salt thereof;
- in the manufacture of a medicament for the treatment of HIV-1 infections or HBV infections.
A pharmaceutical composition for the treatment of HIV-1 infections or HBV infections comprising the (R)-enantiomer of the triphosphate of a compound of formula (A):
- or a pharmaceutically acceptable salt thereof,
- and a pharmaceutically acceptable carrier.
A compound which is bioprecursor of (R)-PCV-TP, which is a derivative of (R)-PCV-MP.
Dependencies are inferred from the claim text.